NasdaqCM - Delayed Quote • USD
Co-Diagnostics, Inc. (CODX)
At close: April 25 at 4:00 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | -- |
| Avg. Estimate | -0.21 | -0.22 | -0.99 | 0 |
| Low Estimate | -0.21 | -0.22 | -0.99 | 0 |
| High Estimate | -0.21 | -0.22 | -0.99 | 0 |
| Year Ago EPS | -0.2 | -0.31 | -1.2 | -0.99 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 1 |
| Avg. Estimate | 3.05M | 2.55M | 5.82M | 63.74M |
| Low Estimate | 3.05M | 2.55M | 5.82M | 63.74M |
| High Estimate | 3.05M | 2.55M | 5.82M | 63.74M |
| Year Ago Sales | 601k | -- | 6.81M | 5.82M |
| Sales Growth (year/est) | 407.50% | -- | -14.60% | 995.20% |
Earnings History
| CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
|---|---|---|---|---|
| EPS Est. | -0.22 | -0.24 | -0.29 | -0.2 |
| EPS Actual | -0.2 | -0.31 | -0.2 | -0.5 |
| Difference | 0.02 | -0.07 | 0.09 | -0.3 |
| Surprise % | 9.10% | -29.20% | 31.00% | -150.00% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -0.21 | -0.22 | -0.99 | 0 |
| 7 Days Ago | -0.21 | -0.22 | -0.99 | -0.1 |
| 30 Days Ago | -0.21 | -0.22 | -0.99 | -0.1 |
| 60 Days Ago | -0.21 | -0.22 | -1 | -0.1 |
| 90 Days Ago | -0.21 | -0.22 | -1 | -0.1 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | CODX | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | -5.00% | -- | -- | 2.60% |
| Next Qtr. | 29.00% | -- | -- | 13.40% |
| Current Year | 17.50% | -- | -- | 5.20% |
| Next Year | -- | -- | -- | 13.30% |
| Next 5 Years (per annum) | -- | -- | -- | 11.11% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Maintains | HC Wainwright & Co.: Neutral to Neutral | 3/15/2024 |
| Reiterates | HC Wainwright & Co.: Neutral to Neutral | 12/29/2023 |
| Maintains | HC Wainwright & Co.: Neutral to Neutral | 11/13/2023 |
| Maintains | HC Wainwright & Co.: Neutral to Neutral | 8/14/2023 |
| Reiterates | HC Wainwright & Co.: Neutral to Neutral | 5/15/2023 |
| Downgrade | HC Wainwright & Co.: Buy to Neutral | 3/20/2023 |
Related Tickers
VREX Varex Imaging Corporation
16.90
-1.05%
XAIR Beyond Air, Inc.
1.1750
-8.20%
TMCI Treace Medical Concepts, Inc.
10.30
-3.47%
QDEL QuidelOrtho Corporation
39.69
-2.77%
AXDX Accelerate Diagnostics, Inc.
0.9453
+1.54%
AIMD Ainos, Inc.
1.0400
-0.95%
THMO ThermoGenesis Holdings, Inc.
0.6800
+4.62%
SRTS Sensus Healthcare, Inc.
3.3300
+0.91%
NURO NeuroMetrix, Inc.
4.4100
+0.68%
NAOV NanoVibronix, Inc.
0.7500
0.00%